Cargando…

Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma

Cancers of the urinary tract are one of the most common malignancies worldwide, causing high morbidity and mortality, and representing a social burden. Upper tract urothelial carcinoma (UTUC) accounts for 5–10% of urinary tract cancers, and its oncogenic mechanisms remain elusive. We postulated that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Eric Yi-Hsiu, Chen, Yu-Kuang, Ou, Chen-Pu, Chen, Yi-Ting, Chen, Sung-Fang, Huang, William J., Liang, Kung-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687567/ https://www.ncbi.nlm.nih.gov/pubmed/36428492 http://dx.doi.org/10.3390/biomedicines10112925

Ejemplares similares

Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence
por: Huang, Eric Yi-Hsiu, et al.
Publicado: (2023)

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
por: Yang, Chen-Kuang, et al.
Publicado: (2014)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis
por: Yu, Wenhua, et al.
Publicado: (2017)

Ureteral Involvement and Diabetes Increase the Risk of Subsequent Bladder Recurrence after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
por: Hu, Che-Yuan, et al.
Publicado: (2015)

Promiscuous RNA binding by Polycomb Repressive Complex 2
por: Davidovich, Chen, et al.
Publicado: (2013)

G-tract RNA removes Polycomb Repressive Complex 2 from genes
por: Beltran, Manuel, et al.
Publicado: (2019)

Molecular architecture of polycomb repressive complexes
por: Chittock, Emily C., et al.
Publicado: (2017)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
por: Meireles, Sara, et al.
Publicado: (2023)

Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2
por: Justin, Neil, et al.
Publicado: (2016)

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
por: Lee, Yi-Ying, et al.
Publicado: (2016)

Trends of incidence and prognosis of upper tract urothelial carcinoma
por: Wu, Jianping, et al.
Publicado: (2021)

Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients
por: Ho, Cheng-Ju, et al.
Publicado: (2021)

Huntingtin facilitates polycomb repressive complex 2
por: Seong, Ihn Sik, et al.
Publicado: (2010)

The structure of Polycomb-repressed chromatin in the bithorax complex
por: Bowman, Sarah K, et al.
Publicado: (2013)

Evolutionary adaptation of the Polycomb repressive complex 2
por: Fischer, Sabrina, et al.
Publicado: (2022)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Laparoscopic nephroureterectomy for upper tract urothelial carcinoma – Update
por: Lin, Victor C., et al.
Publicado: (2016)

Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma
por: Zhong, Wenlong, et al.
Publicado: (2022)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
por: He, Hong-Lin, et al.
Publicado: (2023)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2022)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
por: Chen, Chuan-Shu, et al.
Publicado: (2020)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder
por: Wang, Yuding, et al.
Publicado: (2013)

Ureteritis cystica mimicking upper tract urothelial cancer in a patient with bladder cancer
por: Muraki, Peter H., et al.
Publicado: (2021)

Molecular architecture of human polycomb repressive complex 2
por: Ciferri, Claudio, et al.
Publicado: (2012)

Polycomb repressive complex 1 controls uterine decidualization
por: Bian, Fenghua, et al.
Publicado: (2016)

The molecular principles of gene regulation by Polycomb repressive complexes
por: Blackledge, Neil P., et al.
Publicado: (2021)

Polycomb Repressive Complex 2 in Eukaryotes—An Evolutionary Perspective
por: Vijayanathan, Mallika, et al.
Publicado: (2022)

The ACF chromatin-remodeling complex is essential for Polycomb repression
por: Wiles, Elizabeth T, et al.
Publicado: (2022)

Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer
por: Dong, Guan-Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i30q3lm78ukrvsn99k8vv08snl